Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideTMOThermo Fisher Scientific
FinDog View：Neutral
| Metric | DXCM | TMO |
|---|
| Close | 82.29 | 697.00 |
| Market Cap | $31.3B | $258B |
| 1M | −4.64% | +3.25% |
| P/E (TTM) | 30.2 | 36.4 |
| Forward P/E | 29.8 | 24.6 |
| P/E 5-Yr Percentile | 5 | 78 |
| P/S | 6.1 | 5.4 |
| P/B | 11.5 | 4.7 |
| Dividend Yield | — | 0.29% |
| Latest Quarter Revenue | $1.3B | $12.1B |
| Revenue YoY | +11.2% | +9.1% |
| Gross Margin | 64.3% | — |
| Latest Quarter EPS | 0.72 | 4.64 |
| Avg Post-Earnings Move | ±9.4% | ±1.2% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.28% | 1.82% |
| 90-Day Net Insider Buying | −$4.9M | −$40.3M |
DXCM · Revenue, Last 8 Quarters ($B)
TMO · Revenue, Last 8 Quarters ($B)
